|
|
||||||||
1 Department of Pathology, College of Veterinary Medicine, University of Georgia, Athens, Georgia 30602, USA
2 Department of Medical Microbiology and Parasitology, College of Veterinary Medicine, University of Georgia, Athens, Georgia 30602, USA
3 Armed Forces Institute of Pathology, Washington, DC 20306-6000, USA
4 Oklahoma Animal Disease Diagnostic Laboratory and Department of Veterinary Pathology, College of Veterinary Medicine, Oklahoma State University, Stillwater, Oklahoma 74078, USA
5 Department of Pathobiology and Veterinary Science, University of Connecticut, Storrs, Connecticut 06269-3089, USA
7 Corresponding author (email: jstanton{at}vetmed.wsu.edu)
| ABSTRACT |
|---|
|
|
|---|
Key words: Canine distemper, CDV, immunohistochemistry, phocine distemper, PDV, RT-PCR, seal.
| INTRODUCTION |
|---|
|
|
|---|
Because of their similar clinical presentations, antigenic similarities, and overlapping host ranges (Bilexenkrone-Møller, 1993), CDV and PDV can be difficult to distinguish by routine methods. Accurate diagnostic assays for these two viruses are of paramount importance considering their global distribution, broad host ranges, variety of presentations (Bilexenkrone-Møller, 1993), and history of mass mortality events (Osterhaus and Vedder, 1988; Roelke-Parker et al., 1996). Determining the specific virus responsible for a distemper outbreak is critical to understanding the epizootiology of outbreaks and implementing effective wildlife management strategies. Further complicating the diagnosis of distemper in marine mammals is the inherent difficulty of monitoring and sampling live marine mammals in their wild habitats. Stranding circumstances often necessitate that diagnoses be based on necropsy of carcasses with postmortem changes that render them unsuitable for virologic analysis. Because of these constraints, use of multiple tests has become the best diagnostic strategy for detection of morbillivirus infection, and development of new diagnostic assays is an important means of optimizing this strategy. The goal of this investigation was to develop assays based on reverse transcriptase polymerase chain reaction (RT-PCR) and immunohistochemistry (IHC) for detection of CDV and PDV. These assays were then evaluated for their ability to differentiate these viruses in formalin-fixed paraffin-embedded (FFPE) phocine tissues.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Formalin-fixed paraffin-embedded tissues from a Caspian seal collected from Azerbaijan in 1997 (Forsyth et al., 1998), a hooded seal collected from the New Jersey (USA) coast in 1998 (Lipscomb et al., 2001), a harp seal collected from the Gulf of St. Lawrence (Canada) in 1991 (Daoust et al., 1993), and a harbor seal collected in 1988 from the coast of Northern Ireland (Kennedy et al., 1989) were obtained for evaluation. All samples had been previously determined to be infected with either CDV or PDV by different methods. For the Caspian seal, RT-PCR and nucleotide sequencing of frozen tissue specimens were positive for CDV; IHC on FFPE samples was negative (Forsyth et al., 1998). Southern blotting, RT-PCR, and IHC were used on FFPE tissue of the hooded seal to demonstrate the presence of PDV (Lipscomb et al., 2001). Immunohistochemistry was performed on FFPE tissues to detect PDV antigen in the harbor and harp seals (Kennedy et al., 1989; Daoust et al., 1993). The harbor seal was collected during the 1988 outbreak, in which the virus was isolated and more fully investigated from other seals from this epizootic (Osterhaus and Vedder, 1988). Autolysis of the samples varied from mild to severe, and formalin fixation time varied from days to months. Tissues included lung (harbor, harp, and hooded seals), kidney (harbor and harp seals), brain (harp seal), pancreas (Caspian seal), spleen (Caspian seal), stomach (harp seal), liver (harp seal), skin (harp seal), and esophagus (harp seal). Positive controls were tissues from two dogs infected with canine distemper virus (Stanton et al., 2002). Tissue from one aquarium-kept harbor seal that died of a noninfectious condition served as a negative control.
Immunohistochemistry
Three-micrometer sections of FFPE blocks were cut onto positively charged slides (Probe-On Plus, Fisher Scientific, Springfield, New Jersey). Viral antigens were retrieved by exposing slides immersed in citrate buffer (Antigen Unmasking Solution, Vector Laboratories Inc., Burlingame, California, USA) to microwaves. Nonspecific binding sites were blocked with a commercially available blocking solution (Power Block, BioGenex, San Ramon, California) or 2% goat serum. Slides were then incubated with one of eight primary antibodies. A commercially available mouse monoclonal anti-CDV nucleoprotein antibody (VMRD Inc., Pullman, Washington, USA) was used at a dilution of 1:3,000 as the positive control antibody. Experimental monoclonal antibodies (Mabs) included four antibodies made against PDV (2-1F7, 3-5A12, 2-4D9, and 3-2H1) and three Mabs made against cetacean morbillivirus (CMV: 1-3C1, 1-5B5, and 1-8H1). Protocols were optimized for each primary antibody resulting in dilutions of 1:250, 1:250, 1:50, 1:250, 1:50, 1:250, and 1:50, respectively. A secondary biotinylated goat anti-mouse immunoglobulin-G (IgG) antibody (DAKO Corp., Carpinteria, California) was applied to samples at a dilution of 1:250, followed by signal amplification with avidin-biotinconjugated peroxidase (Elite Peroxidase, Vector Laboratories Inc.). Finally, the antigen-antibody complex was visualized by its reaction with 3,3'-diaminobenzidine (DAB). Slides were counterstained lightly with hematoxylin and coverslipped. For simplicity, the experimental Mabs mentioned heretofore will be referred to as PDV1, PDV2, PDV3, PDV4, CMV1, CMV2, and CMV3, respectively.
Reverse transcriptase polymerase chain reaction
Extraction of RNA and RT-PCR were performed as previously described (Stanton et al., 2002). Briefly, total RNA was isolated from FFPE blocks containing one or more tissues from a single animal by deparaffinization, phenol/chloroform extraction, and ethanol precipitation. Reverse transcriptase polymerase chain reaction for CDV nucleic acid was performed as a seminested RT-PCR technique. Primers were selected on the basis of three criteria: 1) amplicon size of approximately 150 base pairs (bp), 2) conserved sequences between CDV and PDV at sites of primer hybridization, and 3) variable sequences between primer locations. The following primers were used: CDV1, 5'-AACTGC AGAGTCTTCCCATC-3' antisense primer (bases 285304); CDV2, 5'-GGCGAAGATTAT TCCGAAGG-3' sense primer (bases 135154); and CDV3, 5'-AATGCTTCATCTAACTGGGG-3' internal primer (bases 156175). The targeted amplification sequence was a 149-bp fragment spanning bases 156304 of the phosphoprotein gene (Onderstepoort strain, M32418).
Amplicons were separated by agarose gel electrophoresis and visualized by ethidium bromide staining and ultraviolet transillumination. Bands of the appropriate molecular mass were excised from gels, and DNA was extracted (Qiagen Gel Extraction Kit, Valencia, California) and subjected to direct sequencing by oligonucleotide-directed dideoxynucleotide chain termination cycle sequencing reactions. Beta-actin mRNA served as a control for the extraction of amplifiable RNA from tissue blocks, as previously described (Stanton et al., 2002).
Molecular phylogenetic analysis
Six PDV and 32 CDV sequences that included the region amplified by the seminested RT-PCR were collected from GenBank (www.ncbi.nlm.nih.gov/Genbank/) and used with the four sequences obtained from this study for phylogenetic analysis. Sequences were aligned and formatted by ClustalX (v1.81; Thompson et al., 1997). With PAUP* (v4.0b10; Swofford 2000), a maximum parsimony consensus tree was computed using the stepwise-addition option and a heuristic search method with 1,000 bootstrap replicates. Groups with a frequency greater than 50% were retained, and rinderpest virus and measles virus sequences were designated as outgroups.
| RESULTS |
|---|
|
|
|---|
|
Only pulmonary and renal tissues were available in multiple cases. In these tissues the degree of nonspecific staining was not affected by the seal species.
The seminested RT-PCR yielded an amplicon of the appropriate molecular weight in all cases previously identified by other laboratories as positive for either CDV or PDV. Nucleotide sequence analyses of the amplicons allowed for definitive differentiation between CDV- and PDV-infected cases (Figs. 1
, 2
), and the genetic sequences obtained also provided for further analysis of the infecting viruses. Nucleotide sequence analyses of amplicons from PDV-infected cases demonstrated a high degree of nucleotide sequence identity. The only variation among amplicons from the PDV-infected cases tested was a one nucleotide difference found in the amplicon from tissues of the harp seal (AY332388). There was 100% agreement between the nucleotide sequence of the PDV amplicon from the harbor seal collected on the coast of Ireland in 1988 (AY332390) and that from the hooded seal collected on the US coast in 1998 (AY332389).
|
|
| DISCUSSION |
|---|
|
|
|---|
All four antibodies directed against PDV antigens reacted with both CDV and PDV. Subjectively, PDV3 stained the most intensely, whereas the intensity of the staining was similar among the other three antibodies. The use of these antibodies for immunohistochemical detection of CDV and PDV provided a rapid means of identifying the presence of one of these viruses. Antigen was even detected by these Mabs in the severely autolyzed Caspian seal tissues, which were negative by previous immunohistochemical assays, with Mabs directed toward the hemagglutinin protein of PDV (Kennedy et al., 2000). Immunohistochemical assays such as these also allow for study of the pathogenesis of these viruses via tissue tropism analysis in different marine mammal species. For example, intense staining was found in the epithelium of numerous bronchioles of the harbor and harp seals, but only a few pelvic urothelial cells were positive in these same animals. Also in the harp seal, the brain was positive, indicating simultaneous epithelial and nervous tissue infection.
The seminested RT-PCR used in this assay amplified both CDV and PDV RNA from FFPE tissues. This test was useful to confirm cases that were weakly positive by IHC because of severe autolysis. When combined with nucleotide sequence analysis, this test also provided a definitive means for differentiating CDV and PDV. Unfortunately, the small product size of this novel RT-PCR limited its ability to determine strain variations, and analysis of large fragments of the genomes would be required for more definitive phylogenetic characterization.
Reverse transcriptase polymerase chain reaction assays that make use of FFPE tissues are limited to shorter target sequences and a paucity of amplifiable RNA. Inability to amplify longer genetic sequences is a consequence of formalin fixation, which results in chemical modifications of RNA that prevent full-length enzymatic reactions (Masuda et al., 1999). The practical reality is that target sequence size is limited to approximately 150 bp in order to maintain consistent detection of RNA. In the current study, the 149-bp amplicon from the phosphoprotein gene contains enough polymorphism between CDV and PDV to confidently differentiate these viruses. Unfortunately, the amplicon is neither large enough nor sufficiently polymorphic to fully characterize different intraspecific strains, although it can still provide evidence to guide other attempts at strain determination. For example, it was possible to determine that the Caspian seal was infected with a strain of CDV that is likely distinct from the Rockborn or Onderstepoort vaccine strains or from viruses isolated in the Serengeti or Japan. Also, the results of multiple sequence alignments of the RT-PCR products from PDV-infected tissues from several different species of seals indicated that there is high nucleotide sequence identity within this region of the phosphoprotein gene among PDV isolates that had been obtained a decade apart and on opposite sides of the Atlantic ocean (Kennedy et al., 1989; Lipscomb et al., 2001). Examination of additional PDV isolates is required to determine whether PDV is truly less diverse or whether this result is a function of the limited number of isolates examined.
The IHC assays provided a fast and reliable method of detecting the presence of CDV or PDV antigens, but the Mabs used were unable to distinguish between these two viruses. In contrast, the seminested RT-PCR protocol provided distinct, easily interpreted amplicons, even when IHC staining was difficult to evaluate because of autolysis. In addition, direct sequencing of the products of this seminested RT-PCR provided nucleotide sequence data that allowed for virus differentiation. The ability to differentiate these two morbilliviruses from FFPE tissue samples can provide insight into the epizootiology of distemper outbreaks in phocids and assist in deciphering global distribution patterns.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
| LITERATURE CITED |
|---|
|
|
|---|
DAOUST, P.-Y., D. M. HAINES, J. THORSEN, P. J. DUIGNAN, AND J. R. GERACI. 1993. Phocine distemper in a harp seal (Phoca groenlandica) from the Gulf of St. Lawrence, Canada. Journal of Wildlife Diseases 29: 114117.[Abstract]
DEEM, S. L., L. H. SPELMAN, R. A. YATES, AND R. J. MONTALI. 2000. Canine distemper in terrestrial carnivores: A review. Journal of Zoo and Wildlife Medicine 31: 441451.[Medline]
DUIGNAN, P. J., S. SADOVE, J. T. SALIKI, AND J. R. GERACI. 1993. Phocine distemper in harbor seals (Phoca vitulina) from Long Island, New York. Journal of Wildlife Diseases 29: 465469.[Abstract]
FORSYTH, M. A., S. KENNEDY, S. WILSON, T. EYBATOV, AND T. BARRETT. 1998. Canine distemper virus in a Caspian seal. The Veterinary Record
143: 662664.
GEMMA, T., T. WATARI, K. AKIYAMA, N. MIYASHITA, Y. S. SHIN, K. IWATSUKI, C. KAI, AND T. MIKAMI. 1996. Epidemiological observations on recent outbreaks of canine distemper in Tokyo area. The Journal of Veterinary Medical Science 58: 547550.
GRACHEV, M. A., K. P. KUMAREV, L. V. MAMAEV, V. L. ZORIN, L. V. BARANOVA, N. N. DENIKINA, S. I. BELIKOV, E. A. PETROV, V. S. KOLESNIK, R. S. KOLESNIK, V. M. DOROFEEV, A. M. BEIM, V. N. KUDELIN, F. G. NAGIEVA, AND V. N. SIDORV. 1989. Distemper virus in Baikal seals. Nature 338: 209.[Medline]
JAUNIAUX, T., G. BOSERET, M. DESMECHT, J. HAELTERS, C. MANTECA, J. TAVERNIER, J. VAN GOMPEL, AND F. COIGNOUL. 2001. Morbillivirus in common seals stranded on the coasts of Belgium and northern France during summer 1998. The Veterinary Record
148: 587591.
KENNEDY, S., J. A. SMYTH, P. F. CUSH, P. DUIGNAN, M. PLATTEN, S. J. MCCULLOUGH, AND G. M. ALLAN. 1989. Histopathological and immunocytochemical studies of distemper in seals. Veterinary Pathology 26: 97103.[Abstract]
, T. KUIKEN, P. D. JEPSON, R. DEAVILLE, M. FORSYTH, T. BARRETT, M. W. VAN DE BILDT, A. D. OSTERHAUS, T. EYBATOV, C. DUCK, A. KYDYRMANOV, I. MITROFANOV, AND S. WILSON. 2000. Mass die-off of Caspian seals caused by canine distemper virus. Emerging Infectious Diseases 6: 637639.[Medline]
LIPSCOMB, T. P., M. G. MENSE, P. L. HABECKER, J. K. TAUBENBERGER, AND R. SCHOELKOPF. 2001. Morbilliviral dermatitis in seals. Veterinary Pathology
38: 724726.
MASUDA, N., T. OHNISHI, S. KAWAMOTO, M. MONDEN, AND K. OKUBO. 1999. Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples. Nucleic Acids Research
27: 44364443.
OSTERHAUS, A. D. M. E., AND E. J. VEDDER. 1988. Identification of a virus causing recent seal deaths. Nature 335: 20.[Medline]
, J. GROEN, F. G. C. M. UYTDEHAAG, I. K. G. VISSER, M. W. G. VAN DE BILDT, A. BERGMAN, AND B. KLINGEBORN. 1989. Distemper virus in Baikal seals. Nature 338: 210.
, R. L. DE SWART, H. W. VOS, P. S. ROSS, M. J. H. KENTER, AND T. BARRETT. 1995. Morbillivirus infections in aquatic mammals: Newly identified members of the genus. Veterinary Microbiology 44: 219227.[Medline]
ROELKE-PARKER, M., L. MUNSON, C. PACKER, R. KOCK, S. CLEAVELAND, M. CARPENTER, S. J. OBRIEN, A. POSPISCHIL, R. HOFMANN-LEHMANN, H. LUTZ, G. L. M. MWAMENGELE, M. N. MGASA, G. A. MACHANGE, B. A. SUMMERS, AND M. J. G. APPEL. 1996. A canine distemper virus epidemic in Serengeti lions (Panthera leo). Nature 379: 441445.[Medline]
STANTON, J. B., S. POET, S. FRASCA, JR., D. BIENZLE, AND C. C. BROWN. 2002. Development of a semi-nested reverse transcriptase polymerase chain reaction assay for the retrospective diagnosis of canine distemper virus infection. Journal of Veterinary Diagnostic Investigation
14: 4752.
SWOFFORD, D. L. 2000. PAUP*: Phylogenetic analysis using parsimony (* and other methods). Sinauer Associates, Inc., Publishers, Sunderland, Massachusetts.
THOMPSON, J. D., T. J. GIBSON, F. PLEWNIAK, F. JEANMOUGIN, AND D. G. HIGGINS. 1997. The CLUSTAL_X Windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Research
25: 48764882.
VISSER, I. K., E. J. VEDDER, H. W. VOS, M. W. VAN DE BILDT, AND A. D. OSTERHAUS. 1993. Continued presence of phocine distemper virus in the Dutch Wadden Sea seal population. The Veterinary Record 133: 320322.[Medline]
Received for publication 11 July 2002.
This article has been cited by other articles:
![]() |
O. Nielsen, G. Smith, H. Weingartl, S. Lair, and L. Measures USE OF A SLAM TRANSFECTED VERO CELL LINE TO ISOLATE AND CHARACTERIZE MARINE MAMMAL MORBILLIVIRUSES USING AN EXPERIMENTAL FERRET MODEL J. Wildl. Dis., July 1, 2008; 44(3): 600 - 611. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |